Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02NOC
|
|||
| Former ID |
DNCL002693
|
|||
| Drug Name |
Cotara
|
|||
| Synonyms |
Cotara (TN)
Click to Show/Hide
|
|||
| Indication | Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] | Phase 2 | [1] | |
| Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] | Phase 2 | [2] | ||
| Company |
Peregrine Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT00677716) Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.